1. Home
  2. LINC vs NVAX Comparison

LINC vs NVAX Comparison

Compare LINC & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lincoln Educational Services Corporation

LINC

Lincoln Educational Services Corporation

HOLD

Current Price

$40.59

Market Cap

1.7B

Sector

Real Estate

ML Signal

HOLD

Logo Novavax Inc.

NVAX

Novavax Inc.

HOLD

Current Price

$7.51

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LINC
NVAX
Founded
1946
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.5B
IPO Year
2005
1996

Fundamental Metrics

Financial Performance
Metric
LINC
NVAX
Price
$40.59
$7.51
Analyst Decision
Strong Buy
Hold
Analyst Count
4
9
Target Price
$45.00
$11.33
AVG Volume (30 Days)
643.0K
3.6M
Earning Date
05-11-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
100.00
309.76
EPS
0.14
N/A
Revenue
$261,853,000.00
$1,123,479,000.00
Revenue This Year
$15.16
N/A
Revenue Next Year
$9.02
N/A
P/E Ratio
$294.43
N/A
Revenue Growth
32.98
64.69
52 Week Low
$17.29
$6.20
52 Week High
$56.34
$11.85

Technical Indicators

Market Signals
Indicator
LINC
NVAX
Relative Strength Index (RSI) 32.44 30.13
Support Level $38.92 $6.38
Resistance Level $42.69 $10.10
Average True Range (ATR) 2.86 0.37
MACD -1.36 -0.14
Stochastic Oscillator 12.25 2.03

Price Performance

Historical Comparison
LINC
NVAX

About LINC Lincoln Educational Services Corporation

Lincoln Educational Services Corp provides diversified career-oriented post-secondary education to high school graduates and working adults. The company offers programs in automotive technology, skilled trades, healthcare services, hospitality services, and business and information technology. Its reportable segments include: Campus Operations and Transitional. The majority of the revenue is generated from the Campus Operations segment, which includes all campuses that are continuing in operation and contribute to the company's core operations and performance.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, an in-house early-stage R&D business to build a pipeline of high-value assets using its technology along with seeking to enter into partnerships to drive value creation for its assets.

Share on Social Networks: